DK1610785T3 - Farmaceutisk kombination til behandlingen af spasticitet og/eller smerte - Google Patents
Farmaceutisk kombination til behandlingen af spasticitet og/eller smerteInfo
- Publication number
- DK1610785T3 DK1610785T3 DK04726223T DK04726223T DK1610785T3 DK 1610785 T3 DK1610785 T3 DK 1610785T3 DK 04726223 T DK04726223 T DK 04726223T DK 04726223 T DK04726223 T DK 04726223T DK 1610785 T3 DK1610785 T3 DK 1610785T3
- Authority
- DK
- Denmark
- Prior art keywords
- spasticity
- treatment
- pain
- pharmaceutical combination
- combination
- Prior art date
Links
- 208000008238 Muscle Spasticity Diseases 0.000 title abstract 2
- 208000018198 spasticity Diseases 0.000 title abstract 2
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960001985 dextromethorphan Drugs 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0300929A HUP0300929A3 (en) | 2003-04-09 | 2003-04-09 | Analgetic and/or muscle relaxant pharmaceutical composition |
| PCT/HU2004/000032 WO2004089352A2 (en) | 2003-04-09 | 2004-04-07 | Pharmaceutical combination for the treatment of spasticity and/or pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1610785T3 true DK1610785T3 (da) | 2007-10-22 |
Family
ID=90001682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04726223T DK1610785T3 (da) | 2003-04-09 | 2004-04-07 | Farmaceutisk kombination til behandlingen af spasticitet og/eller smerte |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060199841A1 (da) |
| EP (1) | EP1610785B1 (da) |
| JP (1) | JP2006522786A (da) |
| AT (1) | ATE370733T1 (da) |
| CY (1) | CY1106903T1 (da) |
| DE (1) | DE602004008440T2 (da) |
| DK (1) | DK1610785T3 (da) |
| EA (1) | EA007732B1 (da) |
| ES (1) | ES2293245T3 (da) |
| HR (1) | HRP20070441T3 (da) |
| HU (1) | HUP0300929A3 (da) |
| NO (1) | NO20055254L (da) |
| PL (1) | PL1610785T3 (da) |
| PT (1) | PT1610785E (da) |
| RS (1) | RS20050738A (da) |
| WO (1) | WO2004089352A2 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60143671D1 (de) * | 2001-06-07 | 2011-01-27 | Sang Christine | Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor-antagonists |
| US8262942B2 (en) | 2008-02-07 | 2012-09-11 | The George Washington University | Hollow carbon nanosphere based secondary cell electrodes |
| TR201720289A2 (tr) * | 2017-12-13 | 2019-06-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Tolperizon Ve Selektif COX-2 İnhibitörü Kombinasyonları |
| JP7169580B2 (ja) * | 2018-09-27 | 2022-11-11 | 株式会社Ｌｔｔバイオファーマ | 線維症治療用医薬組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5340779A (en) * | 1976-09-21 | 1978-04-13 | Nippon Kayaku Co Ltd | Optically active tolpertisone, their preparation and pharmaceuticals containting the same |
| US4906638A (en) * | 1987-12-22 | 1990-03-06 | Nova Pharmaceutical Corporation | Dextromethorphan potentiator for anticonvulsant composition and method |
| AU2929489A (en) * | 1987-12-22 | 1989-07-19 | John W. FERKANY | Dextrorphan potentiator for anticonvulsant composition and method |
| US5206248A (en) * | 1992-03-27 | 1993-04-27 | Smith Richard A | Method for reducing emotional lability |
| JP4097285B2 (ja) * | 1994-09-22 | 2008-06-11 | リチャード・アラン・スミス | 種々の頑固な疾患の治療のための医薬の製造に有用な組成物 |
| US5840731A (en) * | 1995-08-02 | 1998-11-24 | Virginia Commonwealth University | Pain-alleviating drug composition and method for alleviating pain |
| AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
| CA2264182A1 (en) * | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
| AT409083B (de) * | 1999-04-01 | 2002-05-27 | Sanochemia Pharmazeutika Ag | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung |
| DE10123129A1 (de) * | 2001-05-02 | 2002-11-14 | Berolina Drug Dev Ab Svedala | Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel |
-
2003
- 2003-04-09 HU HU0300929A patent/HUP0300929A3/hu unknown
-
2004
- 2004-04-07 DK DK04726223T patent/DK1610785T3/da active
- 2004-04-07 EP EP04726223A patent/EP1610785B1/en not_active Expired - Lifetime
- 2004-04-07 HR HR20070441T patent/HRP20070441T3/xx unknown
- 2004-04-07 US US10/551,510 patent/US20060199841A1/en not_active Abandoned
- 2004-04-07 PL PL04726223T patent/PL1610785T3/pl unknown
- 2004-04-07 ES ES04726223T patent/ES2293245T3/es not_active Expired - Lifetime
- 2004-04-07 AT AT04726223T patent/ATE370733T1/de not_active IP Right Cessation
- 2004-04-07 DE DE602004008440T patent/DE602004008440T2/de not_active Expired - Fee Related
- 2004-04-07 EA EA200501591A patent/EA007732B1/ru not_active IP Right Cessation
- 2004-04-07 WO PCT/HU2004/000032 patent/WO2004089352A2/en not_active Ceased
- 2004-04-07 RS YUP-2005/0738A patent/RS20050738A/sr unknown
- 2004-04-07 JP JP2006506245A patent/JP2006522786A/ja not_active Withdrawn
- 2004-04-07 PT PT04726223T patent/PT1610785E/pt unknown
-
2005
- 2005-11-08 NO NO20055254A patent/NO20055254L/no not_active Application Discontinuation
-
2007
- 2007-10-02 CY CY20071101259T patent/CY1106903T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004089352A2 (en) | 2004-10-21 |
| DE602004008440T2 (de) | 2008-05-21 |
| DE602004008440D1 (de) | 2007-10-04 |
| NO20055254D0 (no) | 2005-11-08 |
| EA200501591A1 (ru) | 2006-06-30 |
| EP1610785B1 (en) | 2007-08-22 |
| RS20050738A (sr) | 2008-04-04 |
| ATE370733T1 (de) | 2007-09-15 |
| US20060199841A1 (en) | 2006-09-07 |
| PL1610785T3 (pl) | 2008-01-31 |
| PT1610785E (pt) | 2007-09-10 |
| HUP0300929A2 (hu) | 2005-02-28 |
| JP2006522786A (ja) | 2006-10-05 |
| EA007732B1 (ru) | 2006-12-29 |
| EP1610785A2 (en) | 2006-01-04 |
| HRP20070441T3 (hr) | 2007-10-31 |
| HUP0300929A3 (en) | 2005-06-28 |
| CY1106903T1 (el) | 2012-09-26 |
| WO2004089352A3 (en) | 2004-12-16 |
| ES2293245T3 (es) | 2008-03-16 |
| HUP0300929D0 (en) | 2003-06-28 |
| NO20055254L (no) | 2006-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200500203A1 (ru) | Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат | |
| BR0113838A (pt) | Derivados de n-fenil-2-pirimidina-amina | |
| SE0301010D0 (sv) | Novel compounds | |
| SE0301009D0 (sv) | Novel compounds | |
| TW200615266A (en) | Organic compounds | |
| ATE332301T1 (de) | Antivirale pyrazolopyridin verbindungen | |
| CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
| DK1517890T3 (da) | Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
| SE0302139D0 (sv) | Novel compounds | |
| TW200616979A (en) | Non-nucleoside reverse transcriptase inhibitors | |
| DK1594885T3 (da) | Lægemiddel til vækstinhibering af tumorer | |
| EA200600605A1 (ru) | Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств | |
| DK1511472T3 (da) | Anvendelige forbindelser til behandling af Anthrax og hæmning af letalfaktor | |
| SE0402635D0 (sv) | Chemical compounds | |
| CY1106903T1 (el) | Φαρμακευτικος συνδυασμος για τη θεραπεια της σπαστικοτητας και/ή του πονου | |
| DK1970372T3 (da) | Salte af 9-oxoacridin-10-eddikesyre med 1-alkylamino-1-deoxy-polyoler | |
| ATE325809T1 (de) | Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure | |
| ATE374751T1 (de) | 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern | |
| NO20063790L (no) | Substituerte azetidin sammensetninger som cyclooxygenase-1-cyclooxygenase-2-inhibitorer, og deres fremstilling og anvendelse som medikamenter | |
| SE0403117D0 (sv) | New compounds 1 | |
| MXPA05010957A (es) | Derivados de ornitina activos farmaceuticamente, sales de amonio de los mismos y metodos para su preparacion. | |
| TW200640464A (en) | Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient | |
| DE60014915D1 (de) | Hypoxanthin- und thiohypxanthin-verbindungen | |
| DE602004015116D1 (de) | Ammoniumsalze von ornithin-derivaten zur behandlung von enzündlichen erkrankungen | |
| ATE543495T1 (de) | Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür |